Home › Type 2 Diabetes › Nebraska › Omaha
Type 2 Diabetes clinical trials in Omaha, NE
12 studies for Type 2 Diabetes are looking for participants at sites in and around Omaha (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes
RecruitingPhase 2
- Nebraska Cancer Specialists, Omaha
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Quality Clinical Research - Omaha, Omaha
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
RecruitingPhase 3
- University Of Nebraska Medical Center, Omaha
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
RecruitingPhase 3
- Research Site, Elkhorn · 17 mi away
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
RecruitingPhase 3
- Research Site, Omaha
- Research Site, Omaha
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
RecruitingPhase 2
- University of Nebraska Medical Center, Omaha
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
RecruitingPhase 3
- Research Site, Omaha
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
RecruitingPhase 2
- Velocity Clinical Research, Omaha, Omaha
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
RecruitingPhase 3
- Research Site, Omaha
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
RecruitingPhase 3
- Methodist Phys. Clinic, Omaha
- West Broadway Clinic, Council Bluffs · 4 mi away
Blood Markers of Early Pancreas Cancer
RecruitingObservational studyHealthy volunteers welcome
- Unversity of Nebraska Medical Center, Omaha
SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease
Recruiting
- University of Nebraska Medical Center, Omaha
About Type 2 Diabetes
Type 2 Diabetes, previously referred to as Adult Onset Diabetes, is the more common type. Risk factors include obesity and family history.
More about Type 2 Diabetes on MedlinePlus
Type 2 Diabetes trials in other cities
- San Antonio, TX37 studies
- Houston, TX31 studies
- Orlando, FL25 studies
- Atlanta, GA21 studies
- San Diego, CA21 studies
- Boston, MA20 studies
- Miami, FL20 studies
- Chicago, IL19 studies
- Arlington, VA19 studies
- Los Angeles, CA18 studies
- Dallas, TX18 studies
- Columbus, OH17 studies
Other studies in Omaha
- Prostate Cancer29 studies
- Non-Small Cell Lung Cancer25 studies
- Breast Cancer23 studies
- Cancer (all types)19 studies
- Colorectal Cancer18 studies
- Multiple Myeloma17 studies
- Ovarian Cancer15 studies
- Pancreatic Cancer15 studies
- Head and Neck Squamous Cell Carcinoma15 studies
- Metastatic Cancer14 studies
- Non-Hodgkin Lymphoma14 studies
- Lung Cancer13 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.